These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8658806)

  • 1. Alteration of erythrocyte sodium transport in renal transplant recipients.
    Huang JY; Huang CC; Lau YT; Wu MS
    Transplant Proc; 1996 Jun; 28(3):1609-10. PubMed ID: 8658806
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of K+ channel and inhibition of Na(+)-K+ ATPase of human erythrocytes by cyclosporine: possible role in hyperpotassemia in kidney transplant recipients.
    Ihara H; Hosokawa S; Ogino T; Arima M; Ikoma F
    Transplant Proc; 1990 Aug; 22(4):1736-9. PubMed ID: 2167529
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal kinetics of erythrocyte sodium lithium countertransport in renal transplant recipients.
    Vareesangthip K; Hanlakorn P; Suwannaton L; Pidetcha P; Ong-Aj-Yooth L
    Transplant Proc; 2004 Jun; 36(5):1367-71. PubMed ID: 15251334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 in renal transplant recipients.
    el-Sharabasy MM; el-Naggar MN
    Acta Med Hung; 1991; 48(3-4):225-9. PubMed ID: 1822861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of cyclosporine-induced hypertension.
    Cusi D; Barlassina C; Niutta E; Elli A; Quarto di Palo F; Bianchi G
    Clin Invest Med; 1991 Dec; 14(6):607-13. PubMed ID: 1665405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal kinetics of erythrocyte Na/Li countertransport in renal transplant patients treated with cyclosporine.
    Vareesangthip K; Nimmannit S; Vanichakarn S; Pidetcha P; Suwannaton L; Ong-Aj-Yooth L
    Transplant Proc; 2000 Nov; 32(7):1857-8. PubMed ID: 11119971
    [No Abstract]   [Full Text] [Related]  

  • 7. Thiopurine methyltransferase activity and efficacy of azathioprine immunosuppression in transplant recipients.
    Chocair PR; Duley JA; Simmonds HA; Cameron JS
    Adv Exp Med Biol; 1991; 309A():61-4. PubMed ID: 1789271
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraerythrocytic cation metabolism in children with uremia undergoing hemodialysis.
    DeSanto NG; Trevisan M; DeColle S; DiMuro M; DeChiara F; Latte M; Franzese A; Iacono R; Capasso G; Capodicasa G
    J Lab Clin Med; 1987 Aug; 110(2):231-6. PubMed ID: 3598350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of patients with kidney grafts to Sandimmun Neoral normalizes the calcium level in erythrocyts.
    Babarykin D; Amerika D; Adamsone I; Valinietse M; Rosental R
    Transplant Proc; 1996 Dec; 28(6):3137. PubMed ID: 8962215
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet aggregation and peripheral serotonergic system in kidney transplant recipients treated with cyclosporine.
    Malyszko J; Pawlak D; Pawlak K; Malyszko JS; Buczko W; Azzudin A; Mysliwiec M
    Transplant Proc; 1996 Jun; 28(3):1954-7. PubMed ID: 8658959
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythrocyte Na+/Li+ countertransport and Na+/K+ -2Cl- co-transport in essential hypertension.
    Hardman T; Clifford RH; Wierzbicki AS
    Clin Sci (Lond); 1999 Sep; 97(3):339-41. PubMed ID: 10576963
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone mineral density profile in uremic and renal transplant patients.
    Chao SH; Tsai KS; Chieng PU; Lee PH; Lee CJ; Lee CS
    Transplant Proc; 1994 Aug; 26(4):2009-11. PubMed ID: 8066651
    [No Abstract]   [Full Text] [Related]  

  • 13. Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation.
    Vamvakas S; Bahner U; Becker P; Steinle A; Götz R; Heidland A
    Transplant Proc; 1996 Dec; 28(6):3468-73. PubMed ID: 8962350
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there a link between cyclosporine A, altered cellular sodium transport, and arterial pressure in kidney transplant patients?
    Basolo B; Boero R; Guarena C; Forneris G; Formica M; Rollino C; Quarello F; Segoloni GP; Piccoli G
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1307-8. PubMed ID: 1846458
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythrocyte sodium-potassium-ATPase and sodium transport in obesity.
    Mir MA; Charalambous BM; Morgan K; Evans PJ
    N Engl J Med; 1981 Nov; 305(21):1264-8. PubMed ID: 6270558
    [No Abstract]   [Full Text] [Related]  

  • 16. Uremia and red blood cell sodium transport.
    Díez J; Virto R; Yap L; Díaz-Tejeiro R; Errasti P; Purroy A
    Nephron; 1986; 43(2):155-7. PubMed ID: 2423893
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
    Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
    Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia in renal transplant recipients with cyclosporine.
    Kim SI; Yoo TH; Song HY; Hwang JH; Lee HY; Han DS; Moon JI; Kim YS; Park KI; Paeng KJ; Choi KH
    Transplant Proc; 2000 Nov; 32(7):1878-9. PubMed ID: 11119981
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of effect of clinical doses of cyclosporin A on erythrocyte Na+/K+-ATPase activity.
    Ferrer-Martínez A; Felipe A; Barceló P; Casado FJ; Ballarín J; Pastor-Anglada M
    Clin Sci (Lond); 1999 Sep; 97(3):283-90. PubMed ID: 10464053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubular effects of cyclosporine in pediatric renal transplant recipients.
    Laine J; Holmberg C
    Transplant Proc; 1996 Aug; 28(4):2104-6. PubMed ID: 8769167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.